or revisions to any forward-looking statement contained herein to reflect any change in its
Epstein Suite indexes the text; the original document lives at its official source. We don't host the original file — view it on the official release to read it in full.
View the original on the official releaseDocument text
Text is machine OCR and may contain errors. Confirm against the original source above.
or revisions to any forward-looking statement contained herein to reflect any change in its
expectation with regard thereto or any change in events, conditions or circumstances on which
any such statement is based. Due to various risks and uncertainties, actual events or results or
the actual performance of the Fund may differ materially from those reflected or contemplated
in such forward-looking statements. Limited Partners are cautioned not to place undue reliance
on such statements.
THE FOREGOING LIST OF RISK FACTORS AND CONFLICTS OF INTEREST DOES NOT
PURPORT TO BE A COMPLETE EXPLANATION OF THE RISKS INVOLVED IN THIS
OFFERING. PROSPECTIVE INVESTORS ARE URGED TO READ THIS ENTIRE
MEMORANDUM BEFORE DETERMINING TO INVEST IN THE FUND.
72 CONTROL NUMBER 257 - CONFIDENTIAL
HOUSE_OVERSIGHT_024083
Have a question about what this document contains?
Ask the documents